145 related articles for article (PubMed ID: 12353815)
1. Changing incidence of lobular carcinoma in situ of the breast.
Li CI; Anderson BO; Daling JR; Moe RE
Breast Cancer Res Treat; 2002 Oct; 75(3):259-68. PubMed ID: 12353815
[TBL] [Abstract][Full Text] [Related]
2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
3. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
[TBL] [Abstract][Full Text] [Related]
4. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
Li CI; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
[TBL] [Abstract][Full Text] [Related]
5. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
6. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
7. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML
Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097
[TBL] [Abstract][Full Text] [Related]
8. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
9. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
[TBL] [Abstract][Full Text] [Related]
10. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.
Page DL; Kidd TE; Dupont WD; Simpson JF; Rogers LW
Hum Pathol; 1991 Dec; 22(12):1232-9. PubMed ID: 1748429
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for women with lobular carcinoma in situ (LCIS).
Oppong BA; King TA
Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
[TBL] [Abstract][Full Text] [Related]
12. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological survey of preinvasive breast cancer.
Vandenbroucke A; Bourdon C
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
[TBL] [Abstract][Full Text] [Related]
14. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Li CI; Anderson BO; Daling JR; Moe RE
JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
[TBL] [Abstract][Full Text] [Related]
17. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
[TBL] [Abstract][Full Text] [Related]
18. Lobular carcinoma in situ and invasive cancer: the contralateral breast controversy.
Carolin KA; Tekyi-Mensah S; Pass HA
Breast J; 2002; 8(5):263-8. PubMed ID: 12199752
[TBL] [Abstract][Full Text] [Related]
19. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis.
Portschy PR; Marmor S; Nzara R; Virnig BA; Tuttle TM
Ann Surg Oncol; 2013 Oct; 20(10):3240-6. PubMed ID: 23846782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]